Diabetes has become a global health problem and is now considered a pandemic
INTRODUCING A NEW WAY OF DIABETES TREATMENT
Our goal:
Develop a solution that collects data from smart devices, processes these in a data cloud, and on the basis of advanced models visualizes the data in an actionable way.
By doing so, we aim at supporting clinicians and empower people living with type 2 diabetes to improve treatment outcomes and quality of life.
Why is this important?
Diabetes has become a global health problem and is now considered a pandemic
In 2017, prevalence of diabetes was 425 million worldwide and is predicted to increase by more than 200 million in the next 25 years
More than 60% of people do not reach recommended treatment targets
In 2017, prevalence of diabetes was 425 million worldwide and is predicted to increase by more than 200 million in the next 25 years
More than 60% of people do not reach recommended treatment targets
THERE IS A NEED FOR
INNOVATIVE SOLUTIONS
THERE IS A NEED FOR INNOVATIVE SOLLUTIONS
Where technology meets people
Where every clinician is a specialist
to improve outcomes of insulin treatment
Our goal is to develop a solution that collects data from smart devices, processes these in a data cloud, and on the basis of advanced models visualises the data in an actionable way to people living with type 2 diabetes and their clinicians.
Help clinicians manage their patient population and prioritize
“I can see a metric that gives me a clear understanding of how the patient is taking their medication. This reflects glucose data and when doses were administered.
The data are visualized in a meaningful way with additional information where I am used to viewing
the patients’ data.” Help clinicians manage their patients on insulin
“I open the platform during a patient consultation to understand my patient’s blood glucose readings and try to offer advice where to help
The platform provides a basal and bolus recommendation to me. If I agree with the recommendation, I will discuss it with my patient.“ Help clinicians identify the right regimen
“When I am unsure of which treatment regimen I should start my patients on, I provide them with a fully automated closed-loop system consisting of an insulin pump and continuous glucose monitor.
The system takes care of identifying the needs of the individual patient and provides me with a basal and bolus recommendation. If I agree with the recommendation, I will discuss it with my patient.
The automated system allows both me and the patient to focus on all the other important aspects of treating diabetes.“
Our goal is to develop a solution that collects data from smart devices, processes these in a data cloud, and on the basis of advanced models visualises the data in an actionable way to people living with type 2 diabetes and their clinicians.
Help clinicians manage their patient population and prioritize
“I can see a metric that gives me a clear understanding of how the patient is taking their medication. This reflects glucose data and when doses were administered.
The data are visualized in a meaningful way with additional information where I am used to viewing
the patients’ data.”
Help clinicians manage their patients on insulin
“I open the platform during a patient consultation to understand my patient’s blood glucose readings and try to offer advice where to help. The platform provides a basal and bolus recommendation to me. If I agree with the recommendation, I will discuss it with my patient.”
Help clinicians identify the right regimen
“When I am unsure of which treatment regimen I should start my patients on, I provide them with a fully automated closed-loop system consisting of an insulin pump and continuous glucose monitor. The system takes care of identifying the needs of the individual patient and provides me with a basal and bolus recommendation. If I agree with the recommendation, I will discuss it with my patient.”
Creating a better future
for everyone
What features could such a system contain?
Have an overview of your disease and data
Have meaningful discussions with your specialist
Decode the complexity of the treatment
Not convinced yet?
Connected CGMs and insulin pens provide more data with less work.
Unique collaboration of industry leaders and academic experts.
Patients play an active role in achieving their desired treatment outcomes together with their clinicians.
Connected CGMs and insulin pens provide more data with less work
Unique collaboration of industry leaders and academic experts
Patients play an active role in achieving their desired treatment outcomes together with their clinicians
Recent news
Forskere fra tre universiteter – Aalborg Universitet, Danmarks Tekniske Universitet og engelske University of Cambridge – sætter nu gang i et nyt studie med de digitale insulinpenne, som ifølge Novo Nordisk bliver centrale i konkurrencen på fremtidens diabetesmarked.
Nuværende status på forskningsprojektet (September 2021) er, at DiaMonT-studiet er begyndt, og de første fem deltagere er i gang. Flere af projektparterne er gået i gang med at udvikle algoritmer baseret på historiske data, som herefter kan videreudvikles på data fra DiaMonT-studiet.
In this open-label randomized controlled trial patients with T2D on insulin therapy will be randomized to a telemonitoring group (intervention) and a usual care group (control). The telemonitoring group will use various devices at home. Hospital staff will monitor their data for a period of…